Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study.

ABSTRACT:

Objectives

To describe neurodevelopment at age 5 among children born preterm.

Design

Population based cohort study, EPIPAGE-2.

Setting

France, 2011.

Participants

4441 children aged 5½ born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES: Severe/moderate neurodevelopmental disabilities, defined as severe/moderate cerebral palsy (Gross Motor Function Classification System (GMFCS) ≥2), or unilateral or bilateral blindness or deafness, or full scale intelligence quotient less than minus two standard deviations (Wechsler Preschool and Primary Scale of Intelligence, 4th edition). Mild neurodevelopmental disabilities, defined as mild cerebral palsy (GMFCS-1), or visual disability ≥3.2/10 and <5/10, or hearing loss <40 dB, or full scale intelligence quotient (mi

SUBMITTER: Pierrat V 

PROVIDER: S-EPMC8080137 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature